4//SEC Filing
Gelone Steven P. 4
Accession 0001104659-22-106051
CIK 0001641640other
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 9:36 PM ET
Size
5.0 KB
Accession
0001104659-22-106051
Insider Transaction Report
Form 4
Gelone Steven P.
Chief Development Officer
Transactions
- Tax Payment
Ordinary Shares
2022-09-30$2.08/sh−3$6→ 14,449 total
Footnotes (2)
- [F1]These ordinary shares were withheld by the Issuer in order to satisfy tax withholding obligations upon the vesting of certain restricted share units.
- [F2]The number of ordinary shares reported on this Form 4 reflects a 1-for-25 reverse stock split effected on September 15, 2022.
Documents
Issuer
Nabriva Therapeutics plc
CIK 0001641640
Entity typeother
Related Parties
1- filerCIK 0001693064
Filing Metadata
- Form type
- 4
- Filed
- Oct 3, 8:00 PM ET
- Accepted
- Oct 4, 9:36 PM ET
- Size
- 5.0 KB